Skip to main content

Table 3 AEs assessment after 1st TACE procedure of two groups

From: Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus

Adverse Events

DEB-TACE group (n = 42)

TACE group (n = 41)

P-Value

Fever

27 (64.2)

31 (75.6)

0.261#

Abdominal pain

21 (50.0)

29 (70.7)

0.054#

Vomiting

4 (9.5)

8 (19.5)

0.196#

New ascites

5 (11.9)

7 (17.1)

0.503#

GI bleeding

3 (7.1)

6 (14.6)

0.457$

Ischemic cholecystitis

2 (4.7)

6 (14.6)

0.249$

Liver abscess

2 (4.7)

3 (7.3)

0.978$

Hepatic arterial dissection

0 (0)

1 (2.4)

0.494*

Pulmonary/cerebral embolization

0 (0)

0 (0)

…

  1. Data are numbers of events. Data in parentheses are percentages
  2. #Pearson Chi-square was used. $ Continuity correction was used
  3. *Fisher exact test was used
  4. GI-gastrointestinal